(PharmaNewsWire.Com, August 28, 2017 ) The Middle-East and Africa Prostate Cancer Market was worth $3.84 billion in 2016 and estimated to be growing at a CAGR of 9.38%, to reach $6.01 billion by 2021.
Prostate Cancer Market Report is an abnormal and uncontrolled growth of cells in prostate gland of a male individual. Majority of prostate cancers are developed sporadically in which genetic changes occur after birth. Although, cause of the prostate cancer is largely unknown, some of the prime factors associated with the disease include obesity, overweight and past history of certain cancers. A person with cardiovascular disease is more prone to advanced metastatic cancer.
Promising drug pipeline, developing treatment patterns, rising untapped non-metastatic prostate cancer space and increased patient awareness are the factors that are expected to enhance the market growth. Improved government funding towards cancer and growing awareness about prostate cancer would be one of the prime reasons responsible for the unparalleled market growth. Stringent regulations are restraining the growth of the prostate cancer market.
The Middle-East and Africa Prostate Cancer market is segmented on the basis of diagnostic techniques into Digital Rectal Exam (DRE) and Prostate Specific Antigen Test (PSA). Based on surgery the market is segregated into Radical Prostatectomy, Orchidectomy and Trans Urethral Resection (TUR). By radiation therapy, the market is bifurcated into External Beam Radiation Therapy and Brachytherapy. External bean radiation therapy segment is further divided among 3D Conformal Radiation Therapy, Intensity Modulated Radiation Therapy, Stereotactic Body Radiation Therapy and Proton Beam Radiation Therapy. Brachytherapy segment is sub segmented into Permanent Brachytherapy and Temporary Brachytherapy. On the basis of chemotherapy, segments are Docetaxel, Etoposide, Vinblastine, Carboplatin and Vinorelbine. Based on geography the market is analysed under various regions namely, Middle-East and Africa.
Major companies include Sanofi S.A, GlaxoSmithKline, AstraZeneca, AbbVie, Varian Medical Systems, Elekta, Theragenics, Pfizer, Novartis, Roche, Bayer, Johnson & Johnson, Abbott Laboratories, and Genentech etc. The market registered substantial growth in the recent years, due to the various strategies such as opting for agreements and collaborations, adopted by leading market players.
About Us:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
